Dr D. O. Chanter

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
Przuntek et al. [1] report the early termination of a clinical trial in Parkinson's disease (the P R A D O study) because in interim analysis showed significantly higher mortality in the 'standard' t reatment group (L-Dopa in combination with benserazide) compared with those on 'novel' t reatment (a lower dose of the L-Dopa/benserazide combination plus(More)
  • 1